Trilaciclib hydrochloride
CAS : 1977495-97-8
Ref. 3D-CED49597
| 1mg | 738,00 € | ||
| 2mg | 1.081,00 € | ||
| 5mg | 1.929,00 € | ||
| 10mg | 2.469,00 € | ||
| 25mg | 3.704,00 € |
Informations sur le produit
Trilaciclib is a small molecule that inhibits the CDK4/6 complex and is an inhibitor of cell proliferation. It has been shown to inhibit cancer growth in vitro, in vivo, and in humans. Trilaciclib is currently being tested as a treatment for hormone-dependent breast cancer. The drug works by targeting the microenvironment and inhibiting fibroblast growth factor (FGF) from binding to its receptor on the surface of cells. This leads to cell death through apoptosis and immunogenic cell death, which can be used for the treatment of tumors. Trilaciclib also enhances natural killer cell activity, which may help with cancer patients’ immunity against tumor cells.
Propriétés chimiques
Question d’ordre technique sur : 3D-CED49597 Trilaciclib hydrochloride
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
